Oncolytics Biotech (TSE:ONC) has released an update.
Oncolytics Biotech, a leader in immunotherapy for cancer, has announced a conference call to discuss its second quarter financial results and recent company developments. The event is scheduled for August 1, 2024, and will cover corporate updates and financial performance, highlighting the progress of their leading immunotherapeutic agent, pelareorep.
For further insights into TSE:ONC stock, check out TipRanks’ Stock Analysis page.
